We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bisphosphonates Impair Alveolar Bone Healing After Dental Surgery

By HospiMedica International staff writers
Posted on 09 Jun 2009
A new study has found that bisphosphonates can impair healing and slow turnover of alveolar bone even years after the drugs themselves have been discontinued.

Researchers at the University of Colorado Health Sciences Center (Boulder, USA) and in private practice in Houston (TX, USA) described a 73-year-old woman with a three-year history of metastatic breast adenocarcinoma, who had been taking zoledronic acid chronically as treatment. More...
The patient demonstrated numerous residual "ghost” sockets following tooth extractions, which presented lamina dura outlines visible radiographically, signifying chronic ischemia of the jawbone marrow. The patient had almost no ability to heal or remodel the numerous dental extraction sites, even two years after cessation of the bisphosphonate therapy. Moreover, the patient had no secondary risk factors that could explain the development of these residual sockets, which additionally did not heal despite several courses of debridement and treatment with antibiotics. The authors recommend taking heed when encountering such residual sockets, since their presence of could alert the surgeon to potential healing problems in subsequent surgery or trauma of alveolar bone. The study was published in the March/April 2009 issue of General Dentistry.

"Among patients using bisphosphonates, residual sockets provide additional evidence of poor bone healing or very slow bone turnover,” concluded study authors Kishore Shetty, D.D.S., and oral and maxillofacial pathologist Jerry Bouquot, D.D.S., of the department of medicine and surgical dentistry. "It is critical that dentists and oncologists are aware that this significant complication may occur spontaneously or after any dentoalveolar procedure among the population at risk.”

Bisphosphonates are used to slow osteoclastic and osteoblastic activity in patients with bone metastasis, multiple myeloma, osteitis deformans (Paget's disease), osteoporosis, and breast cancer. Hundreds of cases of bisphosphonate-related osteonecrosis of the jaw have been reported, with the mandible twice as frequently affected as the maxilla, and most cases occurring following high-dose intravenous administration used for some cancer patients. Some 60% of cases are preceded by a dental surgical procedure, and it has been suggested that bisphosphonate treatment should be postponed until the dental work has been completed to eliminate potential sites of infection.

Related Links:

University of Colorado Health Sciences Center




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Medical Adhesive
MED 5570U
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.